Institute of Infection, Immunity & Inflammation, University of Glasgow and Respiratory Medicine, Gartnavel General Hospital, Glasgow, G12 OYN, UK.
Expert Rev Respir Med. 2013 Dec;7(6):687-99. doi: 10.1586/17476348.2013.836062. Epub 2013 Oct 22.
Continuous inhaled corticosteroid treatment is highly effective in children and adults with mild persistent asthma, although some therapeutic benefits are not lost if treatment is delayed. Many patients do not adhere to continuous treatment with inhaled corticosteroids, but rather take them intermittently, usually at the time of increased symptoms. Based on these observations it has been proposed that for patients with mild persistent asthma inhaled corticosteroids should be used on-demand when symptoms are troublesome, rather than on a continuous basis. The article reviews the pharmacological properties of inhaled corticosteroids used in clinical trials of on-demand treatment, as well as the evidence for the efficacy and safety of on-demand compared with continuous inhaled corticosteroid treatment of mild persistent asthma in adults and children. The place of on-demand treatment with inhaled corticosteroids in the management of asthma is discussed, as well as future directions for different management strategies for this group.
持续吸入皮质类固醇治疗对儿童和成人轻度持续性哮喘非常有效,尽管如果治疗延迟,一些治疗益处并不会丧失。许多患者不能坚持连续使用吸入皮质类固醇,而是间歇性使用,通常在症状加重时使用。基于这些观察结果,有人提出对于轻度持续性哮喘患者,当症状困扰时,应该按需使用吸入皮质类固醇,而不是连续使用。本文综述了在按需治疗临床试验中使用的吸入皮质类固醇的药理学特性,以及与成人和儿童轻度持续性哮喘的连续吸入皮质类固醇治疗相比,按需治疗的疗效和安全性证据。还讨论了按需使用吸入皮质类固醇在哮喘管理中的地位,以及针对该人群不同管理策略的未来方向。